|

FOLFOXIRI Protocol Clinical Trials

2 actively recruiting trials

Also known as: Bevacizumab, Cetuximab, Panitumumab, modified FOLFIRINOX, modified FOLFOXIRI

Pipeline

Phase 2: 2

Top Sponsors

  • Centre Hospitalier Universitaire Dijon1
  • Al-Azhar University1

Indications

  • Cancer2
  • Colon Cancer Stage 41
  • Neoplasm Malignant1
  • Neuroendocrine Carcinoma1

Other2 trials

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary
Phase 2
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.